Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3113
+0.0013 (0.42%)
Mar 11, 2026, 12:30 PM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $30.34 million as of March 11, 2026. Its market cap has decreased by -62.31% in one year.
Market Cap
30.34M
Enterprise Value
16.08M
1-Year Change
-62.31%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $30.34M, a decrease of -84.32%. That is a compound annual growth rate of -20.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 24.40M | 1.67% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 28.96M |
| NeuroSense Therapeutics | 28.92M |
| Dyadic International | 27.78M |
| Kyntra Bio | 27.67M |
| BriaCell Therapeutics | 27.53M |
| IGC Pharma | 27.39M |
| Passage Bio | 26.95M |
| Evaxion | 26.86M |